Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 13, p. 6208, doi. 10.3390/ijms26136208
- By:
- Publication type:
- Article
Works by Jovanović Stojanov, Sofija
Results: 16
1
2
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models.
- Published in:
- Pharmaceutics, 2025, v. 17, n. 2, p. 189, doi. 10.3390/pharmaceutics17020189
- By:
- Publication type:
- Article
3
Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 826, doi. 10.3390/pharmaceutics16060826
- By:
- Publication type:
- Article
4
Coleon U, Isolated from Plectranthus mutabilis Codd., Decreases P-Glycoprotein Activity Due to Mitochondrial Inhibition.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 7, p. 1942, doi. 10.3390/pharmaceutics15071942
- By:
- Publication type:
- Article
5
Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine.
- Published in:
- Life (2075-1729), 2024, v. 14, n. 9, p. 1142, doi. 10.3390/life14091142
- By:
- Publication type:
- Article
6
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4- d ]pyrimidine Tyrosine Kinase Inhibitors.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 10, p. 1503, doi. 10.3390/life12101503
- By:
- Publication type:
- Article
7
Alpha-1 antitrypsin expression is upregulated in multidrug-resistant cancer cells.
- Published in:
- Histochemistry & Cell Biology, 2023, v. 159, n. 5, p. 431, doi. 10.1007/s00418-022-02172-3
- By:
- Publication type:
- Article
8
Nano-Motion Analysis for Rapid and Label Free Assessing of Cancer Cell Sensitivity to Chemotherapeutics.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 5, p. 446, doi. 10.3390/medicina57050446
- By:
- Publication type:
- Article
9
Pyrazolo[3,4- d ]pyrimidine Tyrosine Kinase Inhibitors Induce Oxidative Stress in Patient-Derived Glioblastoma Cells.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 7, p. 884, doi. 10.3390/brainsci11070884
- By:
- Publication type:
- Article
10
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1984, doi. 10.3390/cancers16111984
- By:
- Publication type:
- Article
11
Modulation of diabetes-related liver injury by the HMGB1/TLR4 inflammatory pathway.
- Published in:
- Journal of Physiology & Biochemistry, 2018, v. 74, n. 2, p. 345, doi. 10.1007/s13105-018-0626-0
- By:
- Publication type:
- Article
12
Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver.
- Published in:
- Journal of Physiology & Biochemistry, 2017, v. 73, n. 4, p. 511, doi. 10.1007/s13105-017-0574-0
- By:
- Publication type:
- Article
13
Catalase inhibition in diabetic rats potentiates DNA damage and apoptotic cell death setting the stage for cardiomyopathy.
- Published in:
- Journal of Physiology & Biochemistry, 2014, v. 70, n. 4, p. 947, doi. 10.1007/s13105-014-0363-y
- By:
- Publication type:
- Article
14
Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures.
- Published in:
- Current Issues in Molecular Biology, 2025, v. 47, n. 4, p. 281, doi. 10.3390/cimb47040281
- By:
- Publication type:
- Article
15
Immunofluorescence-Based Assay for High-Throughput Analysis of Multidrug Resistance Markers in Non-Small Cell Lung Carcinoma Patient-Derived Cells.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 24, p. 3617, doi. 10.3390/diagnostics13243617
- By:
- Publication type:
- Article
16
Anti-melanoma effects of ingenanes isolated from Euphorbia species.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 23, doi. 10.33320/maced.pharm.bull.2022.68.04.006
- By:
- Publication type:
- Article